4-([2,2':6',2''-Terpyridin]-4'-yl)aniline, 95.0%, 5g

Tubastatin A, 25mg

(R)-1-N-Boc-piperazine-2-carboxylic acid methyl ester, 97.0%, 10g

4-Pentynyl methanesulfonate, 95.0%, 2.5g

4,4'-((4H-1,2,4-Triazol-4-yl)methylene)dibenzonitrile, 95.0%, 250mg

1,2-Dicloroetano, mínimo 99 %, para síntesis, 2,5 L, envase de vidrio

2-(5-FLUORO-2-HYDROXY-PHENYL)-2-(1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-N-THIAZOL-2-YL-ACETAMIDE, 95.0%, 5g

1-(4-(Prop-2-yn-1-yl)piperazin-1-yl)ethan-1-one, 97%, 250mg

Amberlyst� 15 hydrogen form dry, 50g

3-Methoxybenzo[d]isothiazole 1,1-dioxide, 97.0%, 100mg

tert-Butyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 1g

Undecyl Ether>97.0%(GC)25g

4-Bromo-2-nitrotoluene>98.0%(GC)25g